The occurrence of cerebrovascular atherosclerosis in Alzheimer's disease patients

Clinical Interventions in Aging

Volumn 8, Issue , 2013, Pages 581-584

  Yuan, Jing ^a   Wen, Ge ^b   Li, Yingjia ^b   Liu, Changxing ^a  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Aging; Alzheimer's disease; Cerebrovascular atherosclerosis; Patients

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTERY CALCIFICATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; BRAIN ANGIOGRAPHY; BRAIN ATHEROSCLEROSIS; CAROTID ATHEROSCLEROSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; MULTIINFARCT DEMENTIA; NEUROIMAGING; NEUROPATHOLOGY; OCCLUSIVE CEREBROVASCULAR DISEASE;

AGING; ALZHEIMER'S DISEASE; CEREBROVASCULAR ATHEROSCLEROSIS; PATIENTS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATHEROSCLEROSIS; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR DISORDERS; CHINA; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84878353350     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S44160     Document Type: Article

References (27)

1. Roher AE, Debbins J P, Malek-Ahmadi M, et al. Cerebral blood fow in Alzheimer's disease. Vasc Health Risk Manag. 2012;8:599-611.
2. Altman R, Rutledge JC. The vascular contribution to Alzheimer's disease. Clin Sci (Lond). 2010;119(10):407-421.
3. Kennelly S P, Lawlor BA, Kenny RA. Blood pressure and the risk for dementia: a double-edged sword. Ageing Res Rev. 2009;8(2): 61-70.
4. Honjo K, Black SE, Verhoeff N P. Alzheimer's disease, cerebrovascular disease, and the β-amyloid cascade. Can J Neurol Sci. 2012;39(6): 712-728.
5. Chu LW. Alzheimer's disease: early diagnosis and treatment. Hong Kong Med J. 2012;18(3):228-237.
6. Hooghiemstra AM, Eggermont LH, Scheltens P, van der Flier WM, Scherder EJ. Exercise and early-onset Alzheimer's disease: theoretical considerations. Dement Geriatr Cogn Dis Extra. 2012;2: 132-145.
7. Grinberg LT, Thal DR. Vascular pathology in the aged human brain. Acta Neuropathol. 2010;119(3):277-290.
8. Veglio F, Paglieri C, Rabbia F, Bisbocci D, Bergui M, Cerrato P. Hypertension and cerebrovascular damage. Atherosclerosis. 2009; 205(2):331-341.
9. Onyike CU. Cerebrovascular disease and dementia. Int Rev Psychiatry. 2006;18(5):423-431.
10. Yarchoan M, Xie SX, Kling MA, et al. Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. Brain. 2012;135(Pt 12):3749-3756.
11. Orsucci D, Mancuso M, Ienco EC, Simoncini C, Siciliano G, Bonuccelli U. Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer's disease. Curr Neurovasc Res. 2013;10(1):76-80.
12. Silvestrini M, Viticchi G, Falsetti L, et al. The role of carotid atherosclerosis in Alzheimer's disease progression. J Alzheimer's Dis. 2011;25(4):719-726.
13. Palacios HH, Yendluri BB, Parvathaneni K, et al. Mitochondrion-specifc antioxidants as drug treatments for Alzheimer disease. CNS Neurol Disord Drug Targets. 2011;10(2):149-162.
14. Rocchi A, Orsucci D, Tognoni G, Ceravolo R, Siciliano G. The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects. Curr Alzheimer Res. 2009;6(3): 224-237.
15. Jicha GA, Parisi JE, Dickson DW, et al. Age and apoE associations with complex pathologic features in Alzheimer's disease. J Neurol Sci. 2008;273(1-2):34-39.
16. Bhat NR. Linking cardiometabolic disorders to sporadic Alzheimer's disease: a perspective on potential mechanisms and mediators. J Neurochem. 2010;115(3):551-562.
17. Beeri MS, Rapp M, Silverman JM, et al. Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Neurology. 2006;66(9):1399-1404.
18. Kosunen O, Talasniemi S, Lehtovirta M, et al. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. Stroke. 1995;26(5):743-748.
19. Moretti R, Torre P, Antonello RM, Manganaro D, Vilotti C, Pizzolato G. Risk factors for vascular dementia: hypotension as a key point. Vasc Health Risk Manag. 2008;4(2):395-402.
20. Weinstein G, Wolf PA, Beiser AS, Au R, Seshadri S. Risk estimations, risk factors, and genetic variants associated with Alzheimer's disease in selected publications from the Framingham Heart Study. J Alzheimers Dis. 2013;33 Suppl 1:S439-S445.
21. Cechetto D F, Hachinski V, Whitehead SN. Vascular risk factors and Alzheimer's disease. Expert Rev Neurother. 2008;8(5):743-750.
22. Rafael H. Cerebral atherosclerosis and mild Alzheimer's disease. Stroke. 2003;34(8):e106.
23. Premkumar DR, Cohen DL, Hedera P, Friedland R P, Kalaria RN. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol. 1996;148(6):2083-2095.
24. Musiek ES, Saboury B, Mishra S, et al. Feasibility of estimation of brain volume and 2-deoxy-2-(18)F-fuoro-D-glucose metabolism using a novel automated image analysis method: application in Alzheimer's disease. Hell J Nucl Med. 2012;15(3):190-196.
25. Westman E, Muehlboeck JS, Simmons A. Combining MRI and CSF measures for classifcation of Alzheimer's disease and prediction of mild cognitive impairment conversion. Neuroimage. 2012;62(1): 229-238.
26. Manook A, Yousef BH, Willuweit A, et al. Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease. PLoS One. 2012;7(3):e31310.
27. Kalback W, Esh C, Castano EM, et al. Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease. Neurol Res. 2004;26(5):525-539.